1 unknown. 1 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Unknown 1 |
Follow Peptide YY: new trials by email Literature Review of Peptide YY trials Research Report on Peptide YY
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| L-Cell Activity in Small Intestine as Biliopancreatic Loop in Obese Patients With DM2 Submitted to RYGBP Analyze basal expression incretin for immunolabeling and mRNA expression glucagon-like secretion peptide-1 (GLP-1) and peptide YY (PYY 3-36) incretins by L cells. - Severe Obesity, Type 2 Diabetes Mellitus in Obese | Not applicable | Unknown | University of Sao Paulo General Hospital | 20 | 2020-02-05 | 2022-07-11 |
Diabetes Mellitus, Type 2 (1) · Obesity, Morbid (1)
University of Sao Paulo General Hospital (1)
Brazil (1)
Marco Aurelio Santo, MD Phd (1) · Priscila Costa Estabile, MsC (1)